Your browser doesn't support javascript.
loading
Feasibility of Serial 6-min Walk Tests in Patients with Acute Heart Failure.
Collins, Sean P; Thorn, Michael; Nowak, Richard M; Levy, Phillip D; Fermann, Gregory J; Hiestand, Brian C; Cowart, Tillman Douglas; Venuti, Robert P; Hiatt, William R; Foo, ShiYin; Pang, Peter S.
Affiliation
  • Collins SP; Department of Emergency Medicine, Vanderbilt University Medical Center and Tennessee Valley Healthcare System, Nashville, TN 37232, USA. sean.collins@vanderbilt.edu.
  • Thorn M; Statistical Resources, Inc., Chapel Hill, NC 27514, USA. mthorn@statisticalresources.com.
  • Nowak RM; Department of Emergency Medicine, Henry Ford Health System, Detroit, MI 48126, USA. rnowak1@hfhs.org.
  • Levy PD; Department of Emergency Medicine and Integrative Biosciences Center, Wayne State University, Detroit, MI 48201, USA. plevy@med.wayne.edu.
  • Fermann GJ; Department of Emergency Medicine, University of Cincinnati, Cincinnati, OH 45267, USA. fermangj@ucmail.uc.edu.
  • Hiestand BC; Wake Forest School of Medicine, Winston Salem, NC 27109, USA. bhiestan@wakehealth.edu.
  • Cowart TD; Therapeutic Development Consultants LLC. dcowart@theradevel.com.
  • Venuti RP; Previously of Cardioxyl Pharmaceuticals, Chapel Hill, NC 27514, USA. rvenuti@nc.rr.com.
  • Hiatt WR; Division of Cardiology, University of Colorado School of Medicine and CPC Clinical Research, Aurora, CO 80045, USA. will.hiatt@cpcmed.org.
  • Foo S; Orchard Biomedical Consulting LLC, Brookline, MA 02446, USA. shiyinfoo@gmail.com.
  • Pang PS; Department of Emergency Medicine & Indianapolis EMS, Indiana University School of Medicine, Indianapolis, IN 46202, USA. ppang@iu.edu.
J Clin Med ; 6(9)2017 Sep 11.
Article in En | MEDLINE | ID: mdl-28891981
ABSTRACT

BACKGROUND:

Functional status assessment is common in many cardiovascular diseases but it has undergone limited study in the setting of acute heart failure (AHF). Accordingly, we performed a pilot study of the feasibility of the six-minute walk test (6MWT) at the emergency department (ED) presentation and through the hospitalization in patients with AHF. METHODS AND

RESULTS:

From November 2014 to February 2015, we conducted a multicenter, observational study of ED patients, aged 18-85 years, whose primary ED admission diagnosis was AHF. Other criteria for enrollment included a left ventricular ejection fraction ≤40%, systolic blood pressure between 90 and 170 mmHg, and verbal confirmation that the patient was able to walk >30 m at the baseline, prior to ED presentation. Study teams were uniformly trained to administer a 6MWT. Patients underwent a baseline 6MWT within 24 h of ED presentation (Day 1) and follow-up 6MWTs at 24 (Day 2), 48 (Day 3), and 120 h (Day 5). A total of 46 patients (65.2% male, 73.9% African American) had a day one mean walk distance of 137.3 ± 78 m, day 2 of 170.9 ± 100 m, and day 3 of 180.8 ± 98 m. The 6MWT demonstrated good reproducibility, as the distance walked on the first 6MWT on Day 3 was similar to the distance on the repeated 6MWT the same day.

CONCLUSIONS:

Our pilot study demonstrates the feasibility of the 6MWT as a functional status endpoint in AHF patients. A larger study in a more demographically diverse cohort of patients is necessary to confirm its utility and association with 30-day heart failure (HF) events.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies Language: En Journal: J Clin Med Year: 2017 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies Language: En Journal: J Clin Med Year: 2017 Document type: Article Affiliation country: United States